Iceland vs Middle East, North Africa, Afghanistan & Pakistan (excluding high income): Antiretroviral therapy coverage

Iceland
88.0%
in 2024
Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
26.5%
in 2024
Iceland rank
23rd
Middle East, North Africa, Afghanistan & Pakistan (excluding high income) rank
22nd

Antiretroviral therapy coverage over time

  • Iceland
  • Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
020406080200020122024

How they compare

Iceland currently reports 88.0% against 26.5% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income), a difference of 61.5%.

That makes Iceland's figure about 3.3 times Middle East, North Africa, Afghanistan & Pakistan (excluding high income)'s.

Across all 25 years both countries report, Iceland has been ahead every year.

Iceland ranks 23rd and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 22nd of 143 countries.

Iceland has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Iceland Middle East, North Africa, Afghanistan & Pakistan (excluding high income) Difference Ahead
2000s 50.5% 3.4% 47.1% Iceland
2010s 72.8% 12.8% 60.0% Iceland
2020s 85.6% 23.1% 62.5% Iceland

Averages of every year both report within each decade.

Frequently asked questions

Which has higher antiretroviral therapy coverage, Iceland or Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
Iceland, at 88.0% against 26.5% in Middle East, North Africa, Afghanistan & Pakistan (excluding high income) as of 2024.
What is the difference in antiretroviral therapy coverage between Iceland and Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
61.5%, with Iceland ahead.
How many years of comparable data are there for Iceland and Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
25 years are reported by both, from 2000 to 2024.
How do Iceland and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) rank globally for antiretroviral therapy coverage?
Iceland ranks 23rd and Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 22nd of 143 countries.
Where does this data come from?
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage (% of people living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Iceland vs Middle East, North Africa, Afghanistan & Pakistan (excluding high income): Antiretroviral therapy coverage. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 19 September 2026, from https://health.statizoid.com/compare/antiretroviral-therapy-coverage-percent-of-people-living-with-hiv/iceland/middle-east-north-africa-afghanistan-and-pakistan-excluding-high-income/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/antiretroviral-therapy-coverage-percent-of-people-living-with-hiv/iceland/middle-east-north-africa-afghanistan-and-pakistan-excluding-high-income/">Iceland vs Middle East, North Africa, Afghanistan & Pakistan (excluding high income): Antiretroviral therapy coverage</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage (% of people living with HIV)
Unit
% of people living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
166 places, 4,061 data points, 2000–2024
Last refreshed

Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.